Our Science. Fractalkine blockers for treatment of inflammation and cancer. Kancera is developing two drug candidates targeting the fractalkine axis and ...
Es fehlt: laubender/ q= https://
Our business. Kancera develops pharmaceuticals for life threatening diseases with high medical needs · Our science. Kancera develops a new class of drugs ...
Es fehlt: laubender/ q=